Healthcare - Biotechnology - NASDAQ - US
$ 4.955
-8.92 %
$ 110 M
Market Cap
-2.27
P/E
Price Target
Average
344.00%
Revenue Forecast
Estimate
400.29%
EBIT
Estimate
--28.07%
Net Income
Estimate
20.04%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
INmune Bio, Inc.
Wall Street analysts predict an average 1-year price target for INMB of $22 , with forecasts ranging from a low of $22 to a high of $22 .
INMB Lowest Price Target
Wall Street Target
22 USD
344.00%
INMB Average Price Target
Wall Street Target
22 USD
344.00%
INMB Highest Price Target
Wall Street Target
22 USD
344.00%
REVENUE FORECAST
Revenue Forecast Chart INMB
EBIT FORECAST
EBIT Forecast Chart INMB
NET INCOME FORECAST
Net Income Chart INMB